Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00104182. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drug(s) in Patients With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to compare the use of Insulin Detemir once a day (morning or evening) to NPH Insulin once a day (evening) when added to treatment with oral antidiabetic drugs in patients with Type 2 diabetes.
Study identification
- NCT ID
- NCT00104182
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 503 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2005 (Type not available)
- Primary completion
- Feb 2006 (Actual)
- Completion
- Feb 2006 (Actual)
- Last update posted
- Jan 30, 2017
2005 – 2006
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35235 | — |
| Novo Nordisk Investigational Site | Mesa | Arizona | 85205 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85029 | — |
| Novo Nordisk Investigational Site | Anaheim | California | 92801 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Fullerton | California | 92835 | — |
| Novo Nordisk Investigational Site | La Jolla | California | 92037 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Orange | California | 92869 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80220 | — |
| Novo Nordisk Investigational Site | Lake Mary | Florida | 32746 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Fall River | Massachusetts | 02721 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Jefferson City | Missouri | 65109 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89030 | — |
| Novo Nordisk Investigational Site | Lewiston | New York | 14092 | — |
| Novo Nordisk Investigational Site | Williamsville | New York | 14221 | — |
| Novo Nordisk Investigational Site | Grand Forks | North Dakota | 58201 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45291 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45406 | — |
| Novo Nordisk Investigational Site | Connellsville | Pennsylvania | 15425 | — |
| Novo Nordisk Investigational Site | Lancaster | Pennsylvania | 17601 | — |
| Novo Nordisk Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Conroe | Texas | 77384 | — |
| Novo Nordisk Investigational Site | Killeen | Texas | 76543 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00104182, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 30, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00104182 live on ClinicalTrials.gov.